On Thursday 19 November 2026, Médecins Sans Frontières (MSF) announced that it has recently called on governments and international funders to strengthen their response to antimicrobial resistance (AMR) in conflict-affected and humanitarian settings, warning that drug-resistant infections pose an increasing threat to vulnerable populations.
The appeal came on Tuesday 17 November 2026, during World Antimicrobial Resistance Awareness Week and the Fourth Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform in Rome, Italy.
According to MSF, more than 2 billion people are estimated to live in conflict-affected settings, while forced displacement affected a record 122 million people in 2025.
The organisation urged governments and funders to invest in national AMR action plans before crises occur, strengthen infection prevention and control, improve access to clean water and sanitation, and expand laboratory and diagnostic capacity. It also called for AMR measures to be included in emergency preparedness, greater protection for healthcare services during conflicts and improved surveillance of drug-resistant infections.
"For the people we treat, antimicrobial resistance is not a 2050 projection. It is a newborn with sepsis, or a person with a war wound, whose infection no longer responds to the antibiotics we have," said Dr Cecilia Ferreyra, infectious diseases specialist and Deputy to the International Medical Secretary of MSF.
She warned that efforts to tackle AMR would fail if people affected by conflict and displacement were excluded, calling for dedicated funding and national action plans adapted to humanitarian emergencies.
MSF highlighted how damaged healthcare facilities, inadequate sanitation, shortages of medical personnel, disrupted supply chains and overcrowded living conditions contribute to the spread of drug-resistant infections.
The organisation currently addresses AMR in more than 20 countries through over 50 projects, focusing on infection prevention, responsible antibiotic use, microbiology-based diagnostics and surveillance.
Dr Rupa Kanapathipillai, Antimicrobial Stewardship Lead at MSF Operational Centre Paris, said: "In Gaza, facilities designed for 250–300 patients a day received as many as 700, with wound care provided from shared trolleys."
She also pointed to South Sudan, Ethiopia and Nigeria, where displaced populations, flooding and disease outbreaks have placed additional pressure on healthcare facilities treating premature babies with sepsis and severely malnourished children.
"Resistance follows displacement and weak health systems, not just the front line," Dr Rupa Kanapathipillai added.
Looking ahead, MSF identified the Fifth Global High-Level Ministerial Conference on AMR, scheduled for Sunday 6 to Tuesday 8 December 2026 in Abuja, Nigeria, as an opportunity for governments to make concrete commitments.
The organisation also highlighted the updated Global Action Plan on AMR, adopted in May 2026, and the planned launch of the Independent Panel for Evidence for Action against AMR.
Pauline Londeix, Advocacy Advisor at MSF Access, called for the panel to address gaps in research and evidence concerning conflict-affected populations.
"Meaningful representation of humanitarian actors, affected communities and low-income countries is also essential to guarantee the Panel’s work responds to the needs of people most at risk," she said.
MSF stressed that international commitments must translate into practical measures to ensure people affected by humanitarian crises can access effective antibiotics, diagnostic tools and appropriate healthcare.